嘉应制药：收到广东证监局警示函

Core Viewpoint - The company, Jiaying Pharmaceutical, received a warning letter from the Guangdong Securities Regulatory Commission due to violations in information disclosure, specifically regarding financial assistance and related party transactions [1] Group 1: Information Disclosure Violations - Jiaying Pharmaceutical failed to disclose financial assistance provided to three non-related enterprises, totaling 65 million yuan, without following the required review procedures and disclosure obligations [1] - The company engaged in related party transactions with Gonghe Pharmaceutical, involving an amount of approximately 8.7558 million yuan, which represents 1.15% of the company's most recent audited net assets, also without adhering to the necessary review and disclosure protocols [1]